Listed life-science companies

809 Nasdaq and NYSE companies, each with its pipeline, dated catalysts and recent results from its SEC filings.

#A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

#

4D Molecular Therapeutics, Inc. FDMT Phase 3 · ophthalmology
60 Degrees Pharmaceuticals, Inc. SXTP Phase 2 · infectious disease

A

Aardvark Therapeutics, Inc. AARD Phase 3 · rare genetic
Abbott Laboratories ABT Approved
AbbVie Inc. ABBV Approved · immunology/inflammation
AbCellera Biologics Inc. ABCL Phase 2 · endocrine/women's health
Abeona Therapeutics Inc. ABEO Pre-clinical · rare genetic
Abivax S.A. ABVX Phase 3 · GI/hepatology
Absci Corp ABSI Phase 1 · dermatology
Abvc Biopharma, Inc. ABVC Phase 2 · CNS/neurology/psychiatry
AC Immune SA ACIU Phase 2 · CNS/neurology/psychiatry
ACADIA Pharmaceuticals Inc. ACAD Phase 3 · CNS/neurology/psychiatry
Accuray Incorporated ARAY oncology
Achieve Life Sciences, Inc. ACHV Phase 3 · CNS/neurology/psychiatry
Aclarion, Inc. ACON pain/anesthesia
Aclaris Therapeutics, Inc. ACRS Phase 2 · immunology/inflammation
Acrivon Therapeutics, Inc. ACRV Phase 2 · oncology
Actinium Pharmaceuticals, Inc. ATNM Phase 1 · oncology
Actuate Therapeutics, Inc. ACTU Phase 2 · oncology
Acumen Pharmaceuticals, Inc. ABOS Phase 2 · CNS/neurology/psychiatry
Acurx Pharmaceuticals, Inc. ACXP Phase 2 · infectious disease
Adagene Inc. ADAG Phase 2 · oncology
Adagio Medical Holdings, Inc. ADGM cardio-renal-metabolic
Adaptive Biotechnologies Corporation ADPT Pre-clinical · hematology
ADARx Pharmaceuticals, Inc. ADRX Phase 3 · rare genetic
ADC Therapeutics SA ADCT Phase 3 · oncology
Addex Therapeutics Ltd. ADXN Pre-clinical · CNS/neurology/psychiatry
Adial Pharmaceuticals, Inc. AZR Pre-clinical · GI/hepatology
Adicet Bio, Inc. ACET Phase 1 · immunology/inflammation
Adlai Nortye Group Ltd. ANL Phase 1 · oncology
ADMA Biologics, Inc. ADMA Pre-clinical · infectious disease
Advanced Biomed Inc. ADVB
AEON Biopharma, Inc. AEON Pre-clinical · CNS/neurology/psychiatry
Aethlon Medical Inc AEMD oncology
Agenus Inc. AGEN Phase 3 · oncology
Agios Pharmaceuticals, Inc. AGIO Phase 3 · hematology
AgomAb Therapeutics AGMB Phase 2 · GI/hepatology
AIM ImmunoTech Inc. AIM Phase 2 · oncology
Akari Therapeutics Plc AKTX Pre-clinical · oncology
Akebia Therapeutics, Inc. AKBA Phase 2 · cardio-renal-metabolic
Aktis Oncology, Inc. AKTS Phase 1 · oncology
Alaunos Therapeutics, Inc. TCRT Pre-clinical · cardio-renal-metabolic
Aldeyra Therapeutics, Inc. ALDX Phase 3 · ophthalmology
Alector, Inc. ALEC Phase 1 · CNS/neurology/psychiatry
Aligos Therapeutics, Inc. ALGS Phase 2 · infectious disease
Alkermes plc. ALKS Phase 3 · CNS/neurology/psychiatry
Allarity Therapeutics, Inc. ALLR Phase 2 · oncology
Allogene Therapeutics, Inc. ALLO Phase 3 · oncology
Alnylam Pharmaceuticals, Inc. ALNY Phase 3 · cardio-renal-metabolic
Alpha Cognition Inc. ACOG Pre-clinical · CNS/neurology/psychiatry
Alpha Tau Medical Ltd. DRTS oncology
Alpha Teknova, Inc. TKNO
Alphatec Holdings, Inc. ATEC
Alterity Therapeutics Ltd ATHE Phase 2 · CNS/neurology/psychiatry
Altimmune, Inc. ALT Phase 3 · GI/hepatology
Alto Neuroscience, Inc. ANRO Phase 2 · CNS/neurology/psychiatry
Alumis Inc. ALMS Phase 3 · immunology/inflammation
Alvotech ALVO Approved · immunology/inflammation
ALX Oncology Holdings Inc. ALXO Phase 2 · oncology
Alzamend Neuro, Inc. ALZN Phase 2 · CNS/neurology/psychiatry
Amarin Corporation plc AMRN Approved · cardio-renal-metabolic
Amgen Inc. AMGN Phase 3 · cardio-renal-metabolic
Amneal Pharmaceuticals, Inc. AMRX Approved · CNS/neurology/psychiatry
Amphastar Pharmaceuticals, Inc. AMPH Phase 3 · endocrine/women's health
Amylyx Pharmaceuticals, Inc. AMLX Phase 3 · endocrine/women's health
AN2 Therapeutics, Inc. ANTX Phase 2 · infectious disease
AnaptysBio, Inc. ANAB oncology
Anavex Life Sciences Corp. AVXL Phase 1 · CNS/neurology/psychiatry
AngioDynamics, Inc. ANGO
ANI Pharmaceuticals, Inc. ANIP Approved
Anika Therapeutics, Inc. ANIK Phase 3 · pain/anesthesia
Anixa Biosciences Inc ANIX Phase 1 · oncology
Annexon, Inc. ANNX Phase 3 · CNS/neurology/psychiatry
Annovis Bio, Inc. ANVS Phase 3 · CNS/neurology/psychiatry
Apimeds Pharmaceuticals US, Inc. APUS Phase 2 · pain/anesthesia
Apnimed, Inc. APMD Phase 3 · respiratory
Apollomics Inc. APLM Phase 2 · oncology
Aprea Therapeutics, Inc. APRE Phase 1 · oncology
Aptevo Therapeutics Inc. APVO Phase 1 · oncology
Apyx Medical Corporation APYX
Aquestive Therapeutics, Inc. AQST Phase 3 · immunology/inflammation
Arbutus Biopharma Corp ABUS Phase 2 · infectious disease
Arcturus Therapeutics Holdings Inc. ARCT Phase 2 · respiratory
Arcus Biosciences, Inc. RCUS Phase 3 · oncology
Arcutis Biotherapeutics, Inc. ARQT Phase 1 · dermatology
Ardelyx, Inc. ARDX Phase 3 · GI/hepatology
Argenx SE ARGX Phase 3 · immunology/inflammation
Armata Pharmaceuticals, Inc. ARMP Phase 2 · infectious disease
ArriVent BioPharma, Inc. AVBP Phase 3 · oncology
Arrowhead Pharmaceuticals, Inc. ARWR Phase 3 · cardio-renal-metabolic
ARS Pharmaceuticals, Inc. SPRY Phase 2 · dermatology
Artelo Biosciences, Inc. ARTL Phase 2 · oncology
Artiva Biotherapeutics, Inc. ARTV Phase 2 · immunology/inflammation
Artivion, Inc. AORT Approved · cardio-renal-metabolic
Arvinas, Inc. ARVN Phase 1 · oncology
Ascendis Pharma A/S ASND Phase 3 · rare genetic
Ascentage Pharma Group International AAPG Phase 3 · oncology
Aspen Neuroscience, Inc. ASPE Phase 2 · CNS/neurology/psychiatry
Aspire-Lakewood Holdings, Inc. ASBP Phase 1 · cardio-renal-metabolic
Assembly Biosciences, Inc. ASMB Phase 1 · infectious disease
Astrazeneca PLC AZN Phase 3 · oncology
Atara Biotherapeutics, Inc. ATRA Phase 3 · oncology
Atea Pharmaceuticals, Inc. AVIR Phase 3 · infectious disease
Atossa Therapeutics, Inc. ATOS Phase 2 · oncology
AtriCure, Inc. ATRC Approved · cardio-renal-metabolic
Atrium Therapeutics, Inc. RNA Pre-clinical · cardio-renal-metabolic
Attovia Therapeutics, Inc. ATTO Phase 1 · immunology/inflammation
aTyr Pharma, Inc. ATYR Pre-clinical · immunology/inflammation
Aura Biosciences, Inc. AURA Phase 3 · oncology
Aurinia Pharmaceuticals Inc. AUPH Phase 1 · immunology/inflammation
Autolus Therapeutics plc AUTL Phase 2 · oncology
Autonomix Medical, Inc. AMIX pain/anesthesia
Avalo Therapeutics, Inc. AVTX Phase 3 · dermatology
Avalyn Pharma Inc. AVLN Phase 2 · respiratory
AVITA Medical, Inc. RCEL Approved · dermatology
Axsome Therapeutics, Inc. AXSM Phase 3 · CNS/neurology/psychiatry
Aytu Biopharma, Inc AYTU Approved · CNS/neurology/psychiatry
Azitra, Inc. AZTR Phase 1 · dermatology

B

Baird Medical Investment Holdings Ltd BDMD oncology
Bambusa Therapeutics, Inc. BBTX Phase 1 · dermatology
Bausch Health Companies Inc. BHC Phase 3 · GI/hepatology
Baxter International Inc. BAX Approved
Beam Therapeutics Inc. BEAM Phase 3 · hematology
Becton Dickinson & Co BDX
Belite Bio, Inc BLTE Phase 3 · ophthalmology
Benitec Biopharma Inc. BNTC Phase 2 · rare genetic
BeOne Medicines Ltd. ONC Phase 3 · hematology
Beta Bionics, Inc. BBNX Phase 3 · endocrine/women's health
Beyond Air, Inc. XAIR Phase 1 · respiratory
BeyondSpring Inc. BYSI Phase 3 · oncology
Bicara Therapeutics Inc. BCAX Phase 3 · oncology
Bicycle Therapeutics PLC BCYC Phase 2 · oncology
BillionToOne, Inc. BLLN Pre-clinical · other
Bio-Techne Corporation TECH
bioAffinity Technologies, Inc. BIAF Pre-clinical · oncology
BioAge Labs, Inc. BIOA Phase 2 · cardio-renal-metabolic
BioCardia, Inc. BCDA Phase 3 · cardio-renal-metabolic
BioCryst Pharmaceuticals, Inc. BCRX Phase 3 · immunology/inflammation
Biodesix, Inc. BDSX
Biodexa Pharmaceuticals Plc BDRX Phase 3 · oncology
Biofrontera Inc. BFRI Phase 3 · dermatology
Biogen Inc. BIIB Phase 3 · CNS/neurology/psychiatry
Biohaven Ltd. BHVN Phase 3 · immunology/inflammation
BioLineRx Ltd. BLRX Phase 2 · oncology
BioMarin Pharmaceutical Inc. BMRN Phase 3 · rare genetic
Biomea Fusion, Inc. BMEA Phase 2 · cardio-renal-metabolic
BioNTech SE BNTX Phase 3 · oncology
BioStem Technologies, Inc. BSEM other
Bioventus Inc. BVS
BioVie Inc. BIVI Phase 2 · CNS/neurology/psychiatry
Black Diamond Therapeutics, Inc. BDTX Phase 2 · oncology
BlossomHill Therapeutics, Inc. BLSM Phase 2 · oncology
Bluejay Diagnostics, Inc. BJDX infectious disease
Bolt Biotherapeutics, Inc. BOLT Phase 1 · oncology
Boston Scientific Corporation BSX Approved
Boundless Bio, Inc. BOLD Pre-clinical · oncology
Brainsway Ltd. BWAY CNS/neurology/psychiatry
Braveheart Bio, Inc. BRVE Phase 3 · cardio-renal-metabolic
BriaCell Therapeutics Corp. BCTX Phase 3 · oncology
BridgeBio Oncology Therapeutics, Inc. BBOT Phase 1 · oncology
BridgeBio Pharma, Inc. BBIO Phase 3 · cardio-renal-metabolic
Bright Minds Biosciences Inc. DRUG Phase 2 · CNS/neurology/psychiatry
Bristol Myers Squibb Co BMY Phase 3 · respiratory
BullFrog AI Holdings, Inc. BFRG Pre-clinical · other
Burning Rock Biotech Ltd BNR oncology

C

C4 Therapeutics, Inc. CCCC Phase 2 · oncology
Cabaletta Bio, Inc. CABA Phase 3 · immunology/inflammation
Cadrenal Therapeutics, Inc. CVKD Phase 2 · hematology
CalciMedica, Inc. CALC Phase 2 · GI/hepatology
Calidi Biotherapeutics, Inc. CLDI Phase 1 · oncology
Camp4 Therapeutics Corp CAMP Phase 1 · CNS/neurology/psychiatry
Can-Fite BioPharma Ltd. CANF Phase 3 · oncology
Candel Therapeutics, Inc. CADL Phase 3 · oncology
Capricor Therapeutics, Inc. CAPR Phase 3 · rare genetic
Cardiff Oncology, Inc. CRDF Phase 2 · oncology
Cardio Diagnostics Holdings, Inc. CDIO cardio-renal-metabolic
Cardiol Therapeutics Inc. CRDL Phase 3 · cardio-renal-metabolic
CareDx, Inc. CDNA other
Caribou Biosciences, Inc. CRBU Phase 1 · oncology
Caris Life Sciences, Inc. CAI oncology
Carlsmed, Inc. CARL
Cartesian Therapeutics, Inc. RNAC Phase 3 · immunology/inflammation
Castle Biosciences, Inc. CSTL
CDT Equity Inc. CDT Pre-clinical · immunology/inflammation
CEL-SCI Corp CVM Phase 3 · oncology
Celcuity Inc. CELC Phase 3 · oncology
Celldex Therapeutics, Inc. CLDX Phase 3 · immunology/inflammation
Cellectar Biosciences, Inc. CLRB Phase 2 · oncology
Cellectis S.A. CLLS Pre-clinical · cardio-renal-metabolic
Celularity Inc CELU Phase 2 · other
Century Therapeutics, Inc. IPSC Phase 1 · immunology/inflammation
Cerenome, Inc. CNSY Phase 2 · oncology
Cerus Corporation CERS Phase 3 · hematology
CervoMed Inc. CRVO Phase 2 · CNS/neurology/psychiatry
CG Oncology, Inc. CGON Phase 3 · oncology
Charles River Laboratories International, Inc. CRL
Chemomab Therapeutics Ltd. CMMB Phase 2 · GI/hepatology
China Pharma Holding Inc. CPHI Approved
China SXT Pharmaceuticals, Inc. SXTC other
Cingulate Inc. CING Phase 3 · CNS/neurology/psychiatry
Citius Oncology, Inc. CTOR Approved · oncology
Citius Pharmaceuticals, Inc. CTXR Phase 3 · oncology
City Therapeutics, Inc. CTY Phase 1 · hematology
Clearmind Medicine Inc. CMND Phase 1 · CNS/neurology/psychiatry
ClearPoint Neuro, Inc. CLPT CNS/neurology/psychiatry
Clene Inc. CLNN Phase 3 · CNS/neurology/psychiatry
Climb Bio, Inc. CLYM Phase 2 · cardio-renal-metabolic
Clinuvel Pharmaceuticals Ltd CUVL Phase 3 · dermatology
CNS Pharmaceuticals, Inc. CNSP Phase 2 · oncology
Co-Diagnostics, Inc. CODX infectious disease
Cocrystal Pharma, Inc. COCP Phase 1 · infectious disease
Cogent Biosciences, Inc. COGT Phase 3 · hematology
Cognition Therapeutics Inc CGTX Phase 2 · CNS/neurology/psychiatry
Coherus Oncology, Inc. CHRS Phase 2 · oncology
Collegium Pharmaceutical, Inc COLL Approved
Compass Pathways plc CMPS Phase 3 · CNS/neurology/psychiatry
Compass Therapeutics, Inc. CMPX Phase 3 · oncology
Compugen Ltd CGEN Phase 1 · oncology
Connect Biopharma Holdings Ltd CNTB Phase 2 · respiratory
Context Therapeutics Inc. CNTX Phase 1 · oncology
Contineum Therapeutics, Inc. CTNM Phase 2 · respiratory
Corbus Pharmaceuticals Holdings, Inc. CRBP Phase 2 · oncology
Corcept Therapeutics Inc CORT Phase 3 · oncology
CorMedix Inc. CRMD Phase 3 · infectious disease
Corvus Pharmaceuticals, Inc. CRVS Phase 3 · oncology
Coya Therapeutics, Inc. COYA Phase 2 · CNS/neurology/psychiatry
Creative Medical Technology Holdings, Inc. CELZ Phase 2 · pain/anesthesia
Crescent Biopharma, Inc. CBIO Phase 1 · oncology
CRISPR Therapeutics AG CRSP Phase 2 · hematology
Cryoport, Inc. CYRX
Cue Biopharma, Inc. CUE Phase 2 · immunology/inflammation
Cullinan Therapeutics, Inc. CGEM Phase 3 · oncology
Cumberland Pharmaceuticals Inc CPIX Phase 2 · rare genetic
Curanex Pharmaceuticals Inc CURX Pre-clinical · GI/hepatology
Curis, Inc. CRIS Phase 2 · oncology
CVRx, Inc. CVRX cardio-renal-metabolic
Cytokinetics Inc CYTK Phase 3 · cardio-renal-metabolic
CytoMed Therapeutics Ltd GDTC Phase 1 · oncology
CytomX Therapeutics, Inc. CTMX Phase 1 · oncology
Cytosorbents Corp CTSO cardio-renal-metabolic

D

Damora Therapeutics, Inc. DMRA Phase 1 · hematology
Dare Bioscience, Inc. DARE Phase 3 · endocrine/women's health
DarioHealth Corp. DRIO cardio-renal-metabolic
DBV Technologies S.A. DBVT Phase 3 · immunology/inflammation
Decoy Therapeutics Inc. DCOY Pre-clinical · infectious disease
Definium Therapeutics, Inc. DFTX Phase 3 · CNS/neurology/psychiatry
Delcath Systems, Inc. DCTH Phase 2 · oncology
Denali Therapeutics Inc. DNLI Phase 2 · rare genetic
Design Therapeutics, Inc. DSGN Phase 2 · rare genetic
DexCom, Inc. DXCM endocrine/women's health
DiaMedica Therapeutics Inc. DMAC Phase 2 · CNS/neurology/psychiatry
Dianthus Therapeutics, Inc. DNTH Phase 3 · CNS/neurology/psychiatry
Disc Medicine, Inc. IRON Phase 3 · hematology
Dogwood Therapeutics, Inc. DWTX Phase 2 · oncology
Dr. Reddy's Laboratories Ltd RDY Phase 3 · other
Dyadic International Inc DYAI Phase 1 · other
Dyne Therapeutics, Inc. DYN Phase 3 · rare genetic

E

Edesa Biotech, Inc. EDSA Phase 3 · respiratory
Edgewise Therapeutics, Inc. EWTX Phase 3 · cardio-renal-metabolic
Editas Medicine, Inc. EDIT Pre-clinical · cardio-renal-metabolic
Eikon Therapeutics, Inc. EIKN Phase 2 · oncology
Elanco Animal Health Incorporated ELAN Approved
Electra Therapeutics, Inc. ETRA Phase 2 · hematology
Eledon Pharmaceuticals, Inc. ELDN Phase 2 · immunology/inflammation
Eli Lilly and Company LLY Phase 3 · cardio-renal-metabolic
Elicio Therapeutics, Inc. ELTX Phase 3 · oncology
Eloxx Pharmaceuticals, Inc. ELOX Phase 2 · rare genetic
Embecta Corp. EMBC
Emergent BioSolutions Inc. EBS Approved
Enanta Pharmaceuticals, Inc. ENTA Phase 2 · infectious disease
enGene Therapeutics Inc. ENGN Phase 2 · oncology
Enliven Therapeutics, Inc. ELVN Phase 3 · oncology
Enlivex Ltd. ENLV Phase 2 · immunology/inflammation
Ensysce Biosciences, Inc. ENSC Phase 3 · pain/anesthesia
Entera Bio Ltd. ENTX Phase 2 · endocrine/women's health
Entrada Therapeutics, Inc. TRDA Phase 2 · neuromuscular/rare genetic
Enveric Biosciences, Inc. ENVB Pre-clinical · CNS/neurology/psychiatry
enVVeno Medical Corporation NVNO other
Equillium, Inc. EQ Pre-clinical · GI/hepatology
Erasca, Inc. ERAS Phase 1 · oncology
Ernexa Therapeutics Inc. ERNA Pre-clinical · oncology
Estrella Immunopharma, Inc. ESLA Phase 2 · oncology
Eton Pharmaceuticals, Inc. ETON Approved · other
Eupraxia Pharmaceuticals Inc. EPRX Phase 2 · GI/hepatology
Evaxion A/S EVAX Phase 2 · oncology
Evolus, Inc. EOLS Pre-clinical · dermatology
Evommune, Inc. EVMN Phase 2 · immunology/inflammation
Evotec SE EVO
Exelixis, Inc. EXEL Phase 3 · oncology
Exicure, Inc. XCUR Phase 2 · hematology
Exozymes Inc. EXOZ Pre-clinical · other

F

Faeth Therapeutics, Inc. FTH Phase 2 · oncology
Fate Therapeutics, Inc. FATE Phase 2 · immunology/inflammation
Femasys Inc FEMY endocrine/women's health
Fennec Pharmaceuticals Inc. FENC Phase 3 · oncology
FibroBiologics, Inc. FBLG Phase 1 · dermatology
Filana Therapeutics, Inc. FLNA Phase 2 · CNS/neurology/psychiatry
First Tracks Biotherapeutics, Inc. TRAX Phase 2 · GI/hepatology
Flyte Aviation, Inc. VJET cardio-renal-metabolic
Foghorn Therapeutics Inc. FHTX Phase 1 · oncology
Fortrea Holdings Inc. FTRE
Fortress Biotech, Inc. FBIO Phase 2 · dermatology
Fractyl Health, Inc. GUTS Pre-clinical · cardio-renal-metabolic
Freenome, Inc. FRNM oncology
Fulcrum Therapeutics, Inc. FULC Pre-clinical
Fulgent Genetics, Inc. FLGT Phase 2 · oncology

G

Gain Therapeutics, Inc. GANX Phase 1 · CNS/neurology/psychiatry
Galectin Therapeutics Inc GALT Phase 2 · GI/hepatology
Galmed Pharmaceuticals Ltd. EOCN Phase 2 · oncology
Genelux Corp GNLX Phase 3 · oncology
Genenta Science S.p.A. GNTA Phase 1 · oncology
Generate Biomedicines, Inc. GENB Phase 3 · respiratory
Genmab A/S GMAB Phase 3 · oncology
Genprex, Inc. GNPX Phase 2 · oncology
GeoVax Labs, Inc. GOVX Phase 2 · oncology
Geron Corporation GERN Phase 2 · hematology
GH Research PLC GHRS Phase 2 · CNS/neurology/psychiatry
Gilead Sciences, Inc. GILD Phase 3 · oncology
Glaukos Corporation GKOS Pre-clinical · ophthalmology
Globus Medical, Inc. GMED
Gossamer Bio, Inc. GOSS Phase 3 · respiratory
Grace Therapeutics, Inc. GRCE Phase 3 · CNS/neurology/psychiatry
GRAIL, Inc. GRAL oncology
Greenwich LifeSciences, Inc. GLSI Phase 3 · oncology
GRI Bio, Inc. GRI Phase 2 · respiratory
Grifols SA GRFS Phase 3 · hematology
GSK plc GSK Phase 3 · infectious disease
GT Biopharma, Inc. GTBP Phase 1 · oncology
Guardant Health, Inc. GH Phase 3 · oncology
Gyre Therapeutics, Inc. GYRE Phase 3 · GI/hepatology

H

Haemonetics Corporation HAE Approved
Halozyme Therapeutics, Inc. HALO Phase 3 · other
Harmony Biosciences Holdings, Inc. HRMY Phase 3 · CNS/neurology/psychiatry
Harrow, Inc. HROW Approved · ophthalmology
HCW Biologics Inc. HCWB Phase 1 · immunology/inflammation
HeartBeam, Inc. BEATW cardio-renal-metabolic
Heartflow, Inc. HTFL cardio-renal-metabolic
Helus Pharma Inc. HELP Phase 3 · CNS/neurology/psychiatry
Hemab Therapeutics Holdings, Inc. COAG Phase 2 · hematology
Heron Therapeutics, Inc. HRTX Pre-clinical · pain/anesthesia
Humacyte, Inc. HUMA Phase 3 · cardio-renal-metabolic
HUTCHMED (China) Ltd HCM Phase 3 · oncology

I

Iambic Therapeutics, Inc. IAM Phase 1 · oncology
iBio, Inc. IBIO Phase 1 · cardio-renal-metabolic
IceCure Medical Ltd. ICCM oncology
ICU Medical, Inc. ICUI
IDEAYA Biosciences, Inc. IDYA Phase 3 · oncology
IDEXX Laboratories IDXX
IGC Pharma, Inc. IGC Phase 2 · CNS/neurology/psychiatry
ImageneBio, Inc. IMA Phase 2 · immunology/inflammation
Immatics N.V. IMTX Phase 3 · oncology
Immix Biopharma, Inc. IMMX Phase 2 · hematology
Immucell Corp ICCC infectious disease
Immuneering Corp IMRX Phase 3 · oncology
Immunic, Inc. IMUX Phase 3 · CNS/neurology/psychiatry
ImmunityBio, Inc. IBRX Phase 3 · oncology
Immunocore Holdings plc IMCR Phase 3 · oncology
Immunome Inc. IMNM Phase 3 · oncology
Immunovant, Inc. IMVT Phase 3 · immunology/inflammation
Immuron Ltd IMRN Phase 2 · infectious disease
Immutep Limited IMMP Phase 2 · oncology
Impact Biomedical Inc. IBO
Imunon, Inc. IMNN Phase 3 · oncology
IN8BIO, Inc. INAB Pre-clinical · immunology/inflammation
Incannex Healthcare Inc. IXHL Phase 2 · respiratory
Incyte Corp INCY Phase 3 · hematology
Indaptus Therapeutics, Inc. INDP Pre-clinical · oncology
Indivior PLC SUPN Approved
InflaRx N.V. IFRX Phase 2 · immunology/inflammation
InfuSystem Holdings, Inc INFU
Inhibikase Therapeutics, Inc. IKT Phase 3 · respiratory
Inhibrx Biosciences, Inc. INBX Phase 3 · oncology
InMed Pharmaceuticals Inc. INM Pre-clinical · CNS/neurology/psychiatry
INmune Bio INMB Phase 3 · rare genetic
Innate Pharma SA IPHA Phase 2 · oncology
Innoviva, Inc. INVA Approved
Inovio Pharmaceuticals, Inc. INO Phase 3 · infectious disease
Insight Molecular Diagnostics Inc. IMDX other
INSMED Inc INSM Phase 3 · respiratory
Inspire Medical Systems, Inc. INSP respiratory
InspireMD, Inc. NSPR cardio-renal-metabolic
Instil Bio, Inc. TIL Pre-clinical
Insulet Corporation PODD Phase 3 · endocrine/women's health
Integra LifeSciences Holdings Corporation IART
Intellia Therapeutics, Inc. NTLA Phase 3 · rare genetic
Intelligent Bio Solutions Inc. INBS
Intensity Therapeutics, Inc. INTS Phase 3 · oncology
Inventiva S.A. IVA Phase 3 · GI/hepatology
Invivyd, Inc. IVVD Phase 3 · infectious disease
INVO Fertility, Inc. IVF endocrine/women's health
Ionis Pharmaceuticals Inc IONS Phase 3 · cardio-renal-metabolic
Iovance Biotherapeutics, Inc. IOVA Phase 3 · oncology
Iqvia Holdings Inc. IQV
Iradimed Corporation IRMD
iRhythm Technologies, Inc. IRTC cardio-renal-metabolic
Ironwood Pharmaceuticals, Inc. IRWD Phase 3 · GI/hepatology
IRulya Therapeutics Inc. IRLA Phase 2 · respiratory

J

Jade Biosciences, Inc. JBIO Phase 2 · immunology/inflammation
Jaguar Health, Inc. JAGX Phase 3 · GI/hepatology
Janux Therapeutics, Inc. JANX Phase 1 · oncology
Jasper Therapeutics, Inc. JSPR Phase 2 · cardio-renal-metabolic
Jazz Pharmaceuticals plc JAZZ Phase 2 · CNS/neurology/psychiatry
Johnson & Johnson JNJ Approved · oncology
Journey Medical Corp DERM Approved · dermatology
Jupiter Neurosciences, Inc. JUNS Phase 2 · CNS/neurology/psychiatry
Jyong Biotech Ltd. MENS Phase 3 · other

K

Kailera Therapeutics, Inc. KLRA Phase 3 · endocrine/women's health
Kairos Pharma, LTD. KAPA Phase 2 · oncology
Kalaris Therapeutics, Inc. KLRS Phase 1 · ophthalmology
Kamada Ltd KMDA Phase 3 · infectious disease
Kardigan, Inc. KARD Phase 3 · cardio-renal-metabolic
Karyopharm Therapeutics Inc. KPTI Phase 3 · oncology
Kazia Therapeutics Ltd KZIA Phase 2 · oncology
Keros Therapeutics, Inc. KROS Phase 2 · rare genetic
Kestra Medical Technologies, LTD. KMTS cardio-renal-metabolic
Kiniksa Pharmaceuticals KNSA Phase 3 · cardio-renal-metabolic
Kiora Pharmaceuticals, Inc. KPRX Phase 2 · ophthalmology
Kodiak Sciences Inc. KOD Phase 3 · ophthalmology
Korro Bio, Inc. KRRO Phase 1 · GI/hepatology
Korsana Biosciences, Inc. KRSA Pre-clinical · CNS/neurology/psychiatry
KORU Medical Systems, Inc. KRMD immunology/inflammation
Krystal Biotech, Inc. KRYS Phase 3 · dermatology
Kura Oncology, Inc. KURA Phase 3 · oncology
Kymera Therapeutics, Inc. KYMR Phase 2 · immunology/inflammation
Kyntra Bio, Inc. KYNB Phase 2 · oncology
Kyverna Therapeutics, Inc. KYTX Phase 3 · CNS/neurology/psychiatry

L

Labcorp Holdings Inc. LH
Lakefront Biotherapeutics LKFT Phase 2 · immunology/inflammation
Lakewood-Amedex Biotherapeutics Inc. LABT Phase 2 · infectious disease
Lantern Pharma Inc. LTRN Phase 2 · oncology
Lantheus Holdings, Inc. LNTH Phase 3 · oncology
Larimar Therapeutics, Inc. LRMR Phase 2 · rare genetic
Latigo Therapeutics, Inc. LTGO Phase 3 · pain/anesthesia
LB Pharmaceuticals LBRX Phase 3 · CNS/neurology/psychiatry
Legend Biotech Corp LEGN Pre-clinical · oncology
Lemaitre Vascular Inc LMAT
LENSAR, Inc. LNSR ophthalmology
LENZ Therapeutics, Inc. LENZ Approved · ophthalmology
LeonaBio, Inc. LONA Phase 3 · oncology
Lexaria Bioscience Corp. LEXX Phase 1 · cardio-renal-metabolic
Lexeo Therapeutics, Inc. LXEO Phase 2 · cardio-renal-metabolic
Lexicon Pharmaceuticals, Inc. LXRX Phase 3 · cardio-renal-metabolic
Lifecore Biomedical Inc. LFCR
Ligand Pharmaceuticals Inc LGND
Liminatus Pharma, Inc. LIMN Pre-clinical · oncology
Lineage Cell Therapeutics, Inc. LCTX Phase 2 · ophthalmology
Lipocine Inc. LPCN Phase 3 · CNS/neurology/psychiatry
Liquidia Corp LQDA Phase 3 · respiratory
Lisata Therapeutics, Inc. LSTA Phase 2 · oncology
Longeveron Inc. LGVN Phase 2 · cardio-renal-metabolic
Lucid Diagnostics Inc. LUCD GI/hepatology
Lumexa Imaging Holdings, Inc. LMRI
Lunai Bioworks Inc. LNAI Pre-clinical · oncology
Lycia Therapeutics, Inc. LYCA Phase 1 · immunology/inflammation
Lyell Immunopharma, Inc. LYEL Phase 3 · oncology

M

Macrogenics Inc MGNX Phase 1 · oncology
Madrigal Pharmaceuticals, Inc. MDGL Phase 3 · GI/hepatology
MAIA Biotechnology, Inc. MAIA Phase 3 · oncology
MannKind Corporation MNKD Phase 2 · respiratory
MapLight Therapeutics, Inc. MPLT Phase 2 · CNS/neurology/psychiatry
Maravai Lifesciences Holdings, Inc. MRVI
Marker Therapeutics, Inc. MRKR Phase 1 · oncology
Matinas BioPharma Holdings, Inc. MTNB Phase 2 · infectious disease
MaxCyte, Inc. MXCT
Maze Therapeutics, Inc. MAZE Phase 2 · cardio-renal-metabolic
MBX Biosciences, Inc. MBX Phase 2 · endocrine/women's health
MDxHealth SA MDXH oncology
Medicinova Inc MNOV Phase 2 · CNS/neurology/psychiatry
Medicus Pharma Ltd. MDCX Phase 1 · oncology
MediWound Ltd. MDWD Phase 3 · dermatology
Medline Inc. MDLN
Medpace Holdings, Inc. MEDP
MeiraGTx Holdings plc MGTX Phase 3 · ophthalmology
Merck & Co., Inc. MRK Phase 2 · oncology
Mereo BioPharma Group plc MREO Phase 3 · rare genetic
Merit Medical Systems, Inc. MMSI
Mesoblast Ltd MESO Phase 3 · pain/anesthesia
Metagenomi Therapeutics, Inc. MGX Pre-clinical · hematology
MetaVia Inc. MTVA Phase 2 · cardio-renal-metabolic
Microbot Medical Inc. MBOT cardio-renal-metabolic
Milestone Pharmaceuticals Inc. MIST Phase 2 · cardio-renal-metabolic
MIMEDX Group Inc. MDXG Approved
MindWalk Holdings Corp. HYFT Pre-clinical · other
Mineralys Therapeutics, Inc. MLYS Phase 3 · cardio-renal-metabolic
Minerva Neurosciences, Inc. NERV Phase 3 · CNS/neurology/psychiatry
MiniMed Group, Inc. MMED cardio-renal-metabolic
MiNK Therapeutics, Inc. INKT Phase 2 · respiratory
Mira Pharmaceuticals, Inc. MIRA Phase 1 · pain/anesthesia
Mirum Pharmaceuticals, Inc. MIRM Phase 3 · rare genetic
Mobia Medical, Inc. MOBI Approved · CNS/neurology/psychiatry
Moderna, Inc. MRNA Phase 3 · oncology
Modular Medical, Inc. MODD cardio-renal-metabolic
Molecular Partners AG MOLN Phase 2 · oncology
Moleculin Biotech, Inc. MBRX Phase 2 · oncology
Monopar Therapeutics MNPR Phase 3 · rare genetic
Monte Rosa Therapeutics, Inc. GLUE Phase 2 · immunology/inflammation
MoonLake Immunotherapeutics MLTX Phase 3 · dermatology
Mustang Bio, Inc. MBIO Phase 1 · oncology
Myriad Genetics, Inc. MYGN

N

Nanobiotix S.A. NBTX Phase 3 · oncology
Nanoviricides, Inc. NNVC Phase 1 · infectious disease
Nasus Pharma Ltd NSRX Phase 2 · immunology/inflammation
Natera, Inc. NTRA
Nektar Therapeutics NKTR Phase 3 · immunology/inflammation
Neonc Technologies Holdings, Inc. NTHI Phase 2 · oncology
Nephros, Inc. NEPH
NervGen Pharma Corp. NGEN Phase 2 · CNS/neurology/psychiatry
Neumora Therapeutics, Inc. NMRA Phase 1 · CNS/neurology/psychiatry
Neuphoria Therapeutics Inc. NEUP Phase 2 · CNS/neurology/psychiatry
Neurocrine Biosciences NBIX Phase 3 · CNS/neurology/psychiatry
Neurogene Inc. NGNE Phase 2 · CNS/neurology/psychiatry
Neuronetics, Inc. STIM Approved · CNS/neurology/psychiatry
NEUROONE MEDICAL TECHNOLOGIES Corp NMTC CNS/neurology/psychiatry
NeuroPace Inc NPCE CNS/neurology/psychiatry
NeuroSense Therapeutics Ltd. NRSN Phase 2 · CNS/neurology/psychiatry
NewAmsterdam Pharma Co N.V. NAMS Phase 3 · cardio-renal-metabolic
NewcelX Ltd. NCEL Pre-clinical · cardio-renal-metabolic
Nexentis Technologies Ltd. NXTS Pre-clinical · oncology
Nexgel, Inc. NXGL dermatology
NextCure, Inc. NXTC Pre-clinical · oncology
Nkarta, Inc. NKTX Phase 2 · immunology/inflammation
NovaBridge Biosciences NBP Phase 2 · oncology
Novartis AG NVS Phase 3 · cardio-renal-metabolic
Novavax, Inc. NVAX Pre-clinical · GI/hepatology
Novo Nordisk A/S NVO Phase 3 · cardio-renal-metabolic
NovoCure Ltd NVCR Phase 3 · oncology
NRx Pharmaceuticals, Inc. NRXP Phase 3 · CNS/neurology/psychiatry
NuCana plc NCNA Phase 2 · oncology
Nurix Therapeutics, Inc. NRIX Phase 3 · oncology
Nuvation Bio Inc. NUVB Phase 3 · oncology
Nuvectis Pharma, Inc. NVCT Phase 3 · immunology/inflammation
Nyxoah SA NYXH

O

Obsidian Therapeutics, Inc. OBX Phase 2 · oncology
Ocugen, Inc. OCGN Phase 3 · ophthalmology
Ocular Therapeutix, Inc. OCUL Phase 3 · ophthalmology
Oculis Holding AG OCS Phase 3 · ophthalmology
Odyssey Therapeutics, Inc. ODTX Phase 2 · GI/hepatology
OKYO Pharma Ltd OKYO Phase 3 · ophthalmology
Olema Pharmaceuticals, Inc. OLMA Phase 3 · oncology
Omeros Corp OMER Phase 1 · hematology
OmniAb, Inc. OABI Approved
Oncolytics Biotech Inc. ONCY Phase 2 · oncology
Onconetix, Inc. ONCO oncology
OnKure Therapeutics, Inc. OKUR Pre-clinical · oncology
OPKO Health, Inc. OPK Phase 3 · oncology
Optimi Health Corp. OPTH Phase 2 · CNS/neurology/psychiatry
Opus Genetics, Inc. IRD Phase 3 · ophthalmology
Oragenics Inc OGEN Phase 2 · CNS/neurology/psychiatry
Oramed Pharmaceuticals Inc. ORMP Phase 3 · endocrine/women's health
Orasure Technologies Inc OSUR infectious disease
Orchestra BioMed Holdings, Inc. OBIO cardio-renal-metabolic
Organogenesis Holdings Inc. ORGO Phase 3 · dermatology
Organon & Co. OGN Approved · endocrine/women's health
Oric Pharmaceuticals, Inc. ORIC Phase 3 · oncology
Orthofix Medical Inc. OFIX other
OrthoPediatrics Corp. KIDS
Oruka Therapeutics, Inc. ORKA Phase 2 · dermatology
OS Therapies Inc OSTX Phase 2 · oncology
Outlook Therapeutics, Inc. OTLK Approved · ophthalmology
Ovid Therapeutics Inc. OVID Phase 2 · CNS/neurology/psychiatry

P

Pacira BioSciences, Inc. PCRX Phase 2 · pain/anesthesia
Palatin Technologies, Inc. PTN Phase 2 · rare genetic
Palisade Bio, Inc. PALI Phase 1 · GI/hepatology
Palvella Therapeutics, Inc. PVLA Phase 3 · dermatology
Parabilis Medicines, Inc. PBLS Phase 1 · oncology
Pasithea Therapeutics Corp. KTTA Phase 1 · oncology
PAVmed Inc. PAVM GI/hepatology
PDS Biotechnology Corp PDSB Phase 2 · oncology
Pelthos Therapeutics Inc. PTHS Phase 2 · dermatology
Penumbra, Inc. PEN
PepGen Inc. PEPG Phase 2 · rare genetic
Perrigo Company plc PRGO
Personalis, Inc. PSNL oncology
Perspective Therapeutics, Inc. CATX Phase 1 · oncology
Pfizer Inc. PFE Phase 3
PharmaCyte Biotech, Inc. PMCB Pre-clinical · oncology
Pharming Group N.V. PHAR Phase 3 · immunology/inflammation
Pharvaris N.V. PHVS Phase 3 · rare genetic
Phathom Pharmaceuticals, Inc. PHAT Phase 2 · GI/hepatology
Phibro Animal Health Corporation PAHC
Phio Pharmaceuticals Corp. PHIO Phase 2 · oncology
Picard Medical, Inc. PMI cardio-renal-metabolic
Pliant Therapeutics, Inc. PLRX Phase 1 · oncology
Pluri Inc. PLUR Pre-clinical · other
PMV Pharmaceuticals, Inc. PMVP Phase 2 · oncology
Polaryx Therapeutics, Inc. PLYX Phase 2 · rare genetic
PolyPid Ltd. PYPD Phase 3 · infectious disease
Polyrizon Ltd. PLRZ Pre-clinical · respiratory
Praxis Precision Medicines, Inc. PRAX Phase 3 · CNS/neurology/psychiatry
Precigen, Inc. PGEN Phase 2 · infectious disease
Precision BioSciences, Inc. DTIL Phase 1 · infectious disease
Prelude Therapeutics Inc PRLD Phase 1 · oncology
Prestige Consumer Healthcare Inc. PBH
PRF Technologies Ltd. PRFX Phase 1 · ophthalmology
Prime Medicine, Inc. PRME Phase 1 · rare genetic
Pro-Dex, Inc. PDEX
PROCEPT BioRobotics Corporation PRCT other
Processa Pharmaceuticals, Inc. PCSA Phase 1 · immunology/inflammation
Profound Medical Corp. PROF oncology
Profusa, Inc. PFSA cardio-renal-metabolic
Prokidney Corp. PROK Phase 3 · cardio-renal-metabolic
ProMIS Neurosciences Inc. PMN Phase 1 · CNS/neurology/psychiatry
Propanc Biopharma, Inc. PPCB Pre-clinical · oncology
ProQR Therapeutics N.V. PRQR Phase 1 · GI/hepatology
Protagonist Therapeutics, Inc. PTGX Phase 2 · dermatology
Protalix BioTherapeutics, Inc. PLX Phase 2 · rare genetic
Protara Therapeutics, Inc. TARA Phase 2 · oncology
Prothena Corp Public Ltd Co PRTA Phase 1 · CNS/neurology/psychiatry
Psyence Biomedical Ltd. PBM Phase 2 · CNS/neurology/psychiatry
PTC Therapeutics, Inc. PTCT Phase 3 · rare genetic
Pulmatrix, Inc. PULM Phase 1 · CNS/neurology/psychiatry
Pulmonx Corporation LUNG Phase 3 · respiratory
Pulse Biosciences, Inc. PLSE Phase 3 · cardio-renal-metabolic
Pulsenmore Ltd. PLSM endocrine/women's health
Puma Biotechnology, Inc. PBYI Phase 2 · oncology
Purple Biotech LTD. PPBT Phase 2 · oncology
Pyxis Oncology, Inc. PYXS Phase 2 · oncology

Q

Q32 Bio Inc. QTTB Phase 2 · dermatology
QTREX Quantum Ltd. QTEX respiratory
Quantum BioPharma Ltd. QNTM Phase 1 · CNS/neurology/psychiatry
Quest Diagnostics Incorporated DGX
QuidelOrtho Corp QDEL
Quoin Pharmaceuticals Ltd. QNRX Phase 3 · dermatology

R

Radiopharm Theranostics Ltd RADX Phase 2 · oncology
RadNet, Inc. RDNT
Rafael Holdings, Inc. RFL Phase 3 · rare genetic
Rallybio Corporation RLYB Phase 1 · immunology/inflammation
Rani Therapeutics Holdings, Inc. RANI Phase 1 · cardio-renal-metabolic
Rapport Therapeutics, Inc. RAPP Phase 3 · CNS/neurology/psychiatry
Recursion Pharmaceuticals, Inc. RXRX Phase 2 · GI/hepatology
RedHill Biopharma Ltd. RDHL Phase 2 · GI/hepatology
Regencell Bioscience Holdings Limited RGC Pre-clinical · CNS/neurology/psychiatry
Regeneron Pharmaceuticals, Inc. REGN Phase 2 · cardio-renal-metabolic
REGENXBIO Inc. RGNX Phase 3 · ophthalmology
Rein Therapeutics, Inc. RNTX Phase 2 · respiratory
Relay Therapeutics RLAY Phase 3 · oncology
Relmada Therapeutics, Inc. RLMD Phase 2 · oncology
RenovoRx, Inc. RNXT Phase 3 · oncology
Repligen Corporation RGEN
Replimune Group, Inc. REPL Phase 2 · oncology
Resmed Inc RMD
Retension Pharmaceuticals, Inc. RTSN Phase 2 · cardio-renal-metabolic
Retractable Technologies, Inc. RVP other
Revelation REVB Phase 2 · cardio-renal-metabolic
Revolution Medicines, Inc. RVMD Phase 3 · oncology
Rezolute, Inc. RZLT Phase 3 · endocrine/women's health
Rhythm Pharmaceuticals, Inc. RYTM Phase 3 · rare genetic
Rigel Pharmaceuticals Inc RIGL Phase 1 · hematology
Rocket Pharmaceuticals, Inc. RCKT Phase 2 · rare genetic
Rockwell Medical, Inc. RMTI cardio-renal-metabolic
Roivant Sciences Ltd. ROIV Phase 3 · immunology/inflammation
Royalty Pharma plc RPRX

S

SAB Biotherapeutics, Inc. SABS Phase 2 · endocrine/women's health
Sagimet Biosciences Inc. SGMT Phase 2 · GI/hepatology
Sana Biotechnology, Inc. SANA Pre-clinical · endocrine/women's health
Sanofi SNY Phase 3 · immunology/inflammation
SANUWAVE Health, Inc. SNWV dermatology
Sarepta Therapeutics, Inc. SRPT Phase 3 · rare genetic
Satellos Bioscience Inc. MSLE Phase 2 · rare genetic
Savara Inc SVRA Phase 3 · respiratory
Scholar Rock Holding Corp SRRK Phase 3 · rare genetic
Schrodinger, Inc. SDGR Phase 1 · oncology
Scienture Holdings, Inc. SCNX Approved · cardio-renal-metabolic
Scilex Holding Co SCLX Phase 3 · pain/anesthesia
Scinai Immunotherapeutics Ltd. SCNI Pre-clinical · immunology/inflammation
SciSparc Ltd. SPRC Phase 2 · CNS/neurology/psychiatry
Scribe Therapeutics, Inc. SCTX Phase 1 · cardio-renal-metabolic
SCYNEXIS, Inc. SCYX Phase 1 · rare genetic
Seaport Therapeutics, Inc. SPTX Phase 2 · CNS/neurology/psychiatry
SeaStar Medical Holding Corp ICU cardio-renal-metabolic
Sellas Life Sciences Group, Inc. SLS Phase 3 · hematology
Sensus Healthcare, Inc. SRTS oncology
Senti Biosciences Holdings, Inc. SNTI Phase 1 · oncology
Septerna, Inc. SEPN Phase 1 · other
Sera Prognostics, Inc. SERA endocrine/women's health
Seres Therapeutics, Inc. MCRB Phase 2 · oncology
Serina Therapeutics, Inc. SER Phase 1 · CNS/neurology/psychiatry
Shattuck Labs, Inc. STTK Phase 2 · GI/hepatology
Shoulder Innovations, Inc. SI Phase 1 · other
SI-BONE, Inc. SIBN
SIGA Technologies, Inc. SIGA Phase 3 · infectious disease
Sight Sciences, Inc. SGHT Approved · ophthalmology
Silence Therapeutics plc SLN Phase 2 · hematology
Silexion Therapeutics Corp SLXN Phase 2 · oncology
Silo Pharma, Inc. SILO Pre-clinical · CNS/neurology/psychiatry
Sinovac Biotech Ltd SVA Phase 3 · infectious disease
SINTX Technologies SINT orthopedic
Sionna Therapeutics, Inc. SION Phase 2 · rare genetic
SkinHealth Systems Inc. SKIN
Skye Bioscience, Inc. SKYE Phase 2 · cardio-renal-metabolic
SL Science Holding Ltd SLBT Pre-clinical · oncology
Sol-Gel Technologies Ltd. SLGL Phase 3 · dermatology
Solid Biosciences Inc. SLDB Phase 3 · rare genetic
Soligenix, Inc. SNGX Phase 2 · dermatology
Solventum Corp SOLV
Sonoma Pharmaceuticals, Inc. SNOA dermatology
Spectral AI, Inc. MDAI dermatology
Spero Therapeutics, Inc. SPRO Phase 1 · immunology/inflammation
Spruce Biosciences, Inc. SPRB Phase 2 · rare genetic
SpyGlass Pharma, Inc. SGP Phase 3 · ophthalmology
Spyre Therapeutics, Inc. SYRE Phase 2 · GI/hepatology
SS Innovations International, Inc. SSII other
Standard BioTools Inc. LAB
Stevanato Group S.p.A. STVN
Stoke Therapeutics, Inc. STOK Phase 3 · CNS/neurology/psychiatry
Structure Therapeutics Inc. GPCR Phase 3 · cardio-renal-metabolic
Stryker Corp SYK Approved · other
Summit Therapeutics Inc. SMMT Phase 3 · oncology
Sunshine Biopharma Inc. SBFM Pre-clinical · oncology
Surrozen, Inc. SRZN Pre-clinical · ophthalmology
Sutro Biopharma, Inc. STRO Phase 1 · oncology
Syndax Pharmaceuticals Inc SNDX Phase 3 · oncology

T

Tactile Systems Technology Inc TCMD other
Takeda Pharmaceutical Co Ltd TAK Phase 3 · GI/hepatology
Talphera, Inc. TLPH Phase 3 · cardio-renal-metabolic
Tandem Diabetes Care TNDM Phase 3 · endocrine/women's health
Tango Therapeutics, Inc. TNGX Phase 2 · oncology
Tarsus Pharmaceuticals, Inc. TARS Phase 2 · ophthalmology
Taysha Gene Therapies, Inc. TSHA Phase 2 · rare genetic
Tectonic Therapeutic, Inc. TECX Phase 2 · cardio-renal-metabolic
TELA Bio, Inc. TELA other
Teleflex Incorporated TFX
Telix Pharmaceuticals Ltd TLX Phase 3 · oncology
Telomir Pharmaceuticals, Inc. TELO Phase 1 · oncology
Tempest Therapeutics, Inc. TPST Phase 1 · oncology
Tenax Therapeutics, Inc. TENX Phase 3 · cardio-renal-metabolic
Tenaya Therapeutics, Inc. TNYA Phase 2 · cardio-renal-metabolic
Tenon Medical, Inc. TNON pain/anesthesia
Teva Pharmaceutical Industries Limited TEVA Phase 3 · CNS/neurology/psychiatry
Tevogen Inc. TVGN Phase 1 · infectious disease
TG Therapeutics, Inc. TGTX Phase 3 · CNS/neurology/psychiatry
TherapeuticsMD, Inc. TXMD
Theriva Biologics, Inc. TOVX Phase 2 · oncology
Tiziana Life Sciences Ltd TLSA Phase 2 · CNS/neurology/psychiatry
Tonix Pharmaceuticals Holding Corp. TNXP Phase 2 · pain/anesthesia
Transcode Therapeutics, Inc. RNAZ Phase 1 · oncology
Travere Therapeutics, Inc. TVTX Phase 3 · rare genetic
Traws Pharma, Inc. TRAW Phase 2 · infectious disease
Treace Medical Concepts, Inc. TMCI other
Trevi Therapeutics, Inc. TRVI Phase 3 · respiratory
TRex Bio, Inc. TRXB Phase 1 · immunology/inflammation
Trinity Biotech PLC TRIB endocrine/women's health
TriSalus Life Sciences, Inc. TLSI Phase 1 · oncology
TScan Therapeutics, Inc. TCRX Phase 3 · oncology
TuHURA Biosciences, Inc. HURA Phase 3 · oncology
Turn Therapeutics Inc. TTRX Phase 2 · dermatology
Tvardi Therapeutics, Inc. TVRD Phase 1 · GI/hepatology
Tyra Biosciences, Inc. TYRA Phase 2 · oncology

U

UFP Technologies, Inc. UFPT
Ultragenyx Pharmaceutical Inc. RARE Phase 3 · rare genetic
Unicycive Therapeutics, Inc. UNCY Phase 3 · cardio-renal-metabolic
uniQure N.V. QURE Phase 3 · CNS/neurology/psychiatry
UNITED THERAPEUTICS Corp UTHR Phase 3 · cardio-renal-metabolic
Universe Pharmaceuticals INC UPC
Upstream Bio, Inc. UPB Phase 2 · respiratory
UroGen Pharma Ltd. URGN Phase 3 · oncology
Utah Medical Products Inc UTMD endocrine/women's health

V

Valion Bio, Inc. VBIO Phase 1 · other
Valneva SE VALN Phase 3 · infectious disease
Vanda Pharmaceuticals Inc. VNDA Phase 3 · dermatology
Vaxcyte, Inc. PCVX Phase 3 · infectious disease
Vera Therapeutics, Inc. VERA Phase 2 · cardio-renal-metabolic
Veracyte, Inc. VCYT Pre-clinical · oncology
Veradermics, Inc MANE Phase 3 · dermatology
Verastem Oncology VSTM Phase 3 · oncology
Veraxa Biotech AG - Post de-SPAC VRXA Phase 1 · oncology
Vericel Corporation VCEL Phase 3 · other
Verrica Pharmaceuticals Inc. VRCA Phase 3 · dermatology
Vertex Pharmaceuticals Incorporated VRTX Phase 3 · cardio-renal-metabolic
Veru Inc. VERU Phase 2 · cardio-renal-metabolic
Viatris Inc. VTRS Approved
Vicore Pharma Holding AB VCRE Phase 2 · respiratory
Viking Therapeutics, Inc. VKTX Phase 3 · cardio-renal-metabolic
Vir Biotechnology, Inc. VIR Phase 1 · oncology
Virax Biolabs Group Ltd VRAX infectious disease
Viridian Therapeutics, Inc. VRDN Phase 3 · ophthalmology
Vistagen Therapeutics, Inc. VTGN Phase 3 · CNS/neurology/psychiatry
Vivos Therapeutics, Inc. VVOS respiratory
VivoSim Labs, INC. VIVS Phase 2
Vogenx, Inc. VOGX Phase 2 · endocrine/women's health
Vor Bio VOR Phase 3 · immunology/inflammation
Voyager Therapeutics, Inc. VYGR Phase 1 · CNS/neurology/psychiatry
vTv Therapeutics Inc. VTVT Phase 3 · endocrine/women's health
Vyome Holdings, Inc. HIND Phase 2 · dermatology

W

Wave Life Sciences, Inc. WVE Phase 2 · cardio-renal-metabolic
Werewolf Therapeutics, Inc. HOWL Phase 1 · oncology
West Pharmaceutical Services, Inc. WST
Whitehawk Therapeutics, Inc. WHWK Phase 1 · oncology
WORK Medical Technology Group LTD WOK other

X

X4 Pharmaceuticals, Inc. XFOR Phase 3 · hematology
XBiotech Inc. XBIT Phase 2 · oncology
Xencor Inc XNCR Phase 1 · oncology
Xenetic Biosciences, Inc. XBIO Pre-clinical · oncology
Xenon Pharmaceuticals Inc. XENE Phase 3 · CNS/neurology/psychiatry
Xeris Biopharma Holdings, Inc. XERS Phase 3 · endocrine/women's health
Xilio Therapeutics, Inc. XLO Phase 2 · oncology
XORTX Therapeutics Inc. XRTX Phase 2 · cardio-renal-metabolic
Xtant Medical Holdings, Inc. XTNT other
XTL Biopharmaceuticals Ltd XTLB Pre-clinical · CNS/neurology/psychiatry

Y

Yarrow Bioscience, Inc. YARW Phase 1 · endocrine/women's health
YD Bio Ltd YDES Pre-clinical · oncology

Z

Zai Lab Limited ZLAB Phase 3 · oncology
Zenas BioPharma ZBIO Phase 3 · immunology/inflammation
Zentalis Pharmaceuticals, Inc. ZNTL Phase 3 · oncology
Zevra Therapeutics, Inc. ZVRA Phase 3 · rare genetic
Zhengye Biotechnology Holding Ltd ZYBT infectious disease
Zoetis Inc. ZTS Approved
Zura Bio Limited ZURA Phase 2 · dermatology
Zymeworks Inc. ZYME Phase 1 · oncology

#

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

The free Monday brief